GOODERHAM, M. J.; KIRCIK, L. H.; ZIRWAS, M.; LEE, M.; KEMPERS, S. E.; DRAELOS, Z. D.; FERRIS, L.; JONES, T. M.; SAINT-CYR PROULX, E.; BISSONNETTE, R.; BHATIA, N.; GUENTHNER, S. T.; KOPPEL, R. A.; WELGUS, H.; MERRITT, C.; ELIAS, M.; NAVALE, L.; HIGHAM, R. C.; DROEGE, M.; BERK, D. R. The Safety and Efficacy of Roflumilast Cream 0.15% and 0.05% in Atopic Dermatitis: Phase 2 Proof-of-Concept Study. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 4, n. 6, p. s93, 2020. DOI: 10.25251/skin.4.supp.93. Disponível em: https://www.jofskin.org/index.php/skin/article/view/1063. Acesso em: 21 jan. 2022.